Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48,205Revenue (TTM) $M12,157Net Margin (%)6.5Altman Z-Score2.6
Enterprise Value $M53,319EPS (TTM) $3.5Operating Margin %9.3Piotroski F-Score6
P/E(ttm)60.7Beneish M-Score-2.7Pre-tax Margin (%)5.4Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %5.6Quick Ratio5.0Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %3.0Current Ratio5.6Lower Leverage y-yN
Price/Free Cash Flow34.3y-y EBITDA Growth Rate %-22.1ROA % (ttm)2.9Higher Current Ratio y-yY
Dividend Yield %1.4PEG20.2ROE % (ttm)8.7Less Shares Outstanding y-yN
Payout Ratio %83.0Shares Outstanding M228ROIC % (ttm)6.9Gross Margin Increase y-yY

Gurus Latest Trades with BDX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

BDX is held by these investors:

BDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COHEN GARY MExecutive Vice President 2017-09-11Sell15,512$203.773.96view
Sichak StephenExecutive Vice President 2017-09-08Sell11,787$200.465.67view
Lim James CExecutive Vice President 2017-09-08Sell3,500$204.063.81view
Tharby Linda MExecutive Vice President 2017-08-22Sell4,695$200.485.66view
COHEN GARY MExecutive Vice President 2017-08-22Sell15,044$200.435.69view
Shabshab NabilExecutive Vice President 2017-08-15Sell6,149$201.764.99view
Mas Ribo AlbertoEVP and Pres, Life Sciences 2017-08-14Sell7,463$201.415.17view
Strahlman Ellen RSenior Vice President 2017-08-10Sell9,283$198.216.87view
Polen Thomas E JrExecutive Vice President 2017-08-09Sell5,971$197.417.3view
SHERMAN JEFFREY SSr. VP and General Counsel 2017-05-25Sell28,765$185.9813.9view

Press Releases about BDX :

Quarterly/Annual Reports about BDX:

News about BDX:

Articles On GuruFocus.com
BD Statement On European Commission Conditional Clearance Of Bard Acquisition Oct 18 2017 
6 Quality Stocks With High Business Predictability Ratings Oct 10 2017 
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call Oct 05 2017 
Timothy M. Ring and David F. Melcher to Join BD Board of Directors Sep 29 2017 
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes Sep 27 2017 
BD Expands Efforts to Combat Antimicrobial Resistance with New Diagnostic Test in Europe Sep 26 2017 
BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sep 20 2017 
BD Introduces New 6mm Pen Needle for Injection Pens Sep 19 2017 
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis Sep 12 2017 
BD to Present at the Morgan Stanley Global Healthcare Conference 2017 Sep 08 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat